What's New

Last Posted: Nov 02, 2024

• Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study.
  Xia Zhao, et al. Annals of medicine 2024 0 (1) 2419556
• Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma.
  J D Haslbauer, et al. Infectious agents and cancer 2024 0 (1) 33
• Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
  Francesca Castellani, et al. Neurology(R) neuroimmunology & neuroinflammation 2023 0 (4)
• Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
  Tatarczuch Maciej, et al. Blood advances 2023 0
• Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.
  Jallades Laurent, et al. Haematologica 2017 0 (10) 1758-1766
• Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
  Hyeon Jiyeon, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 0 (9) 1418-1428
• Dural Extranodal Marginal Zone Lymphoma in an XRCC2 Mutation Carrier.
  Gvozdjan Kristina, et al. Journal of neuropathology and experimental neurology 2019 0 (12) 1174-1177
• Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.
  Jaramillo Oquendo Carolina, et al. Scientific reports 2019 0 (1) 10444
• A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
  Varettoni Marzia, et al. British journal of haematology 2019 0 (4) 441-446
• Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
  Gailllard Baptiste, et al. British journal of haematology 2020 0 (1) 72-82
• Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
  Wu Fangtian, et al. Leukemia 2021 0 (12) 3497-3508
• Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.
  Lim Sojung, et al. The American journal of surgical pathology 2022 0 (10) 1397-1406
• Analysis of Genetic Alterations in Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma With Whole-Exome Sequencing.
  Zhao Andi, et al. Frontiers in oncology 2022 0 817635
• Identification of a Cancer-Predisposing Germline POT1 p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma.
  Jajosky Audrey N, et al. Genes 2022 0 (4)
• The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
  Magistri Marco, et al. Cancer research communications 2022 0 (1) 1-16
• Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
  Hernández-Verdin Isaias, et al. International journal of molecular sciences 2020 0 (1)
• Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome.
  Bult Johanna A A, et al. Cancers 2022 0 (4)
• Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma.
  Wu Xiao-Bo, et al. Frontiers in oncology 2022 0 901547
• B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
  Wang Sophia S, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 2
• Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.
  Noy Ariela, et al. Blood advances 2020 11 (22) 5773-5784
• Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
  Din Lennox, et al. Genetic epidemiology 2019 0 (7) 844-863
• FDA Approvals Provide Advances for a Range of Cancer Types
  K Honey, AACR Blogs, August 6, 2019
• High Frequency of MYD88 L265P Mutation in Primary Ocular Adnexal Marginal Zone Lymphoma and Its Clinicopathologic Correlation: A Study From a Single Institution.
  Behdad Amir, et al. Archives of pathology & laboratory medicine 2019 4 (4) 483-493
• Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice.
  Sewastianik Tomasz, et al. Blood advances 2017 11 (25) 2361-2374
• The genetic landscape of dural marginal zone lymphomas.
  Ganapathi Karthik A, et al. Oncotarget 2016 7 (28) 43052-43061
• Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.
  Machiela Mitchell J, et al. Human molecular genetics 2016 4 (8) 1663-76
• Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
  Cao Xin-Xin, et al. Annals of hematology 2017 3
• [IGHV mutational statue in patients with splenic marginal zone lymphoma].
  Yang W J, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016 9 (9) 774-778
• [Molecular analysis of immunoglobulin genes in the tumor B cells in splenic marginal zone lymphoma].
  Julakyan U L, et al. Terapevticheskii? arkhiv 2015 0 (7) 58-63
• MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
  Hamadeh Fatima, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 4 (4) 564-74
• The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
  Arcaini Luca, et al. Haematologica 2015 2 (2) 246-52
• Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
  Martínez N, et al. Leukemia 2014 6 (6) 1334-40
• Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
  Parry Marina, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 9 (18) 4174-83
• Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
  Wang Sophia S, et al. American journal of epidemiology 2015 3 (6) 406-21
• MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
  Martinez-Lopez Azahara, et al. The American journal of surgical pathology 2015 5 (5) 644-51
• A genome-wide association study of marginal zone lymphoma shows association to the HLA region.
  Vijai Joseph, et al. Nature communications 2015 0 5751
• Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
  Varettoni M, et al. Blood 2013 1
• MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
  Treon SP, et al. The New England journal of medicine 2012 8 (9) 9
• Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
  Kiel Mark J, et al. The Journal of experimental medicine 2012 8 (9) 1553-65
• The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
  Hockley Sarah L, et al. British journal of haematology 2012 8 (3) 347-54

More